中国药房2016，Vol.27Issue(5)：581-583,3.DOI:10.6039/j.issn.1001-0408.2016.05.02
3种依达拉奉联合用药方案治疗急性脑梗死的最小成本分析
Cost-minimization Analysis of 3 Therapeutic Regimes of Edaravone Combined Use in the Treatment of Acute Cerebral Infarction
乔媛 1储秋萍2
作者信息
- 1. 南京大学医学院附属鼓楼医院药学部,南京 210008
- 2. 南京医科大学第一附属医院药学部,南京 210029
- 折叠
摘要
Abstract
OBJECTIVE:To explore the pharmacoeconomic effect of Ginkgo dipyidamolum,argatroban or sodium ozagerl combined with edaravone in the treatment of acute cerebral infarction(ACI). METHODS:In retrospective study,64 ACI patients were divided into group A(Ginkgo dipyidamolum+edaravone,22 cases),group B(argatroban+edaravone,19 cases)and group C (sodium ozagerl+edaravone,23 cases). Therapeutic efficacies were observed after 7-14 days of treatment;therapy cost was calculat-ed,and cost-minimization analysis was used to evaluate pharmacoeconomics. RESULTS:There was no statistical significance in to-tal effective rate among 3 groups(P>0.05);the costs of group A,group B and group C were 8 746.36 yuan,10 770.64 yuan and 8 264.67 yuan. Results of sensitivity analysis were in line with those of cost-minimization analysis. CONCLUSIONS:Therapy plan of sodium ozagerl+edaravone is the economical regime in the treatment of ACI .关键词
急性脑梗死/依达拉奉/银杏达莫/阿加曲班/奥扎格雷钠/联合用药/最小成本分析法Key words
Acute cerebral infarction/Edaravone/Ginkgo dipyidamolum/Argatroban/Sodium ozagerl/Drug combination/Cost-minimization analysis分类
医药卫生引用本文复制引用
乔媛,储秋萍..3种依达拉奉联合用药方案治疗急性脑梗死的最小成本分析[J].中国药房,2016,27(5):581-583,3.
